Karo Pharma AB Buy Hold or Sell Recommendation

KARBFDelisted Stock  USD 5.25  0.00  0.00%   
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding Karo Pharma AB is 'Not Rated'. Macroaxis provides Karo Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KARBF positions. The advice algorithm takes into account all of Karo Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Karo Pharma's buy or sell advice are summarized below:
Real Value
4.46
Hype Value
5.25
Market Value
5.25
Naive Value
5.25
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Karo Pharma AB given historical horizon and risk tolerance towards Karo Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Karo Pharma AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
In addition, we conduct extensive research on individual companies such as Karo and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Karo Pharma AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Execute Karo Pharma Buy or Sell Advice

The Karo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Karo Pharma AB. Macroaxis does not own or have any residual interests in Karo Pharma AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Karo Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Karo PharmaBuy Karo Pharma
Not Rated
For the selected time horizon Karo Pharma AB has a Return On Equity of -0.0269, Return On Asset of 0.0017, Profit Margin of (0.05) %, Current Valuation of 2.34 B, Shares Outstanding of 273.26 M and Shares Owned By Insiders of 1.26 %
We provide investment recommendation to complement the last-minute expert consensus on Karo Pharma AB. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Karo Pharma AB is not overpriced, please verify all Karo Pharma AB fundamentals, including its revenue, total debt, number of employees, as well as the relationship between the net income and book value per share . Given that Karo Pharma AB has a price to earning of 262.50 X, we recommend you to check Karo Pharma market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Karo Pharma Trading Alerts and Improvement Suggestions

Karo Pharma AB is not yet fully synchronised with the market data
Karo Pharma AB has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 2.96 B. Net Loss for the year was (17.45 M) with profit before overhead, payroll, taxes, and interest of 1.71 B.
Over 88.0% of the company shares are owned by institutional investors

Karo Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Karo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Karo Pharma Buy or Sell Advice

When is the right time to buy or sell Karo Pharma AB? Buying financial instruments such as Karo Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Karo Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Value Funds Thematic Idea Now

Large Value Funds
Large Value Funds Theme
Funds or Etfs that invest in the undervalued stocks of large-sized companies. The Large Value Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Value Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Karo Pharma AB information on this page should be used as a complementary analysis to other Karo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in Karo Pink Sheet

If you are still planning to invest in Karo Pharma AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karo Pharma's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm